"This is a moment for all of us to reflect on the toll the pandemic has taken, the progress we have made, the lessons we have learned and what we need to do in the year ahead to end this pandemic”, says @DrTedros in last @WHO #covid19 presser of the year.
@DrTedros @WHO "Science is at the core of everything we do and it has advanced at a blistering speed this year”, says @drtedros.
@DrTedros @WHO "There will be setbacks and new challenges in the year ahead”, says @DrTedros. "For example, new variants of #COVID19 and helping people who are tired of the pandemic continue to combat it."
@DrTedros @WHO “Only if countries are looking and testing effectively, will you be able to pick up variants, and adjust strategies to cope”, says @DrTedros. "We must ensure that countries are not punished for transparently sharing, new scientific findings."
@DrTedros @WHO "Early on, we learned that this #SARSCoV2 does not always transmit directly into communities, as does influenza. It starts off in discrete outbreaks and these outbreaks can be contained even if they involve large numbers of persons”, says David Heymann.
@DrTedros @WHO The concept of herd immunity “has been widely misunderstood and still cannot be predicted because of our lack of understanding of immunity and its duration”, says Heymann.
@DrTedros @WHO “It appears at present that the destiny of #SARSCoV2 is to become endemic as for other human coronaviruses, and that it will continue to mutate as it reproduces in human cells, especially in areas of more intense transmission”, says Heymann. “Its final destiny is not yet known.”
@DrTedros @WHO Q from @HelenBranswell: update on variants?
UK has just reported a case-control study, says @mvankerkhove. Scientists “found no significant differences in hospital admissions and case fatality at 28 days, and the occurrence of reinfections”.
@DrTedros @WHO @HelenBranswell @mvankerkhove South African scientists are "in the process of growing the virus and they will be doing neutralization studies as well”, says @mvankerkhove. “They're also looking at the epidemiology of this variant in South Africa to determine if there any changes in transmissibility"
@DrTedros @WHO @HelenBranswell @mvankerkhove I asked about travel restrictions to curb spread of new variants: “RNA viruses tend to mutate”, says Heymann. "So rather than spending a lot of time blocking borders, it might be more important to try to decrease transmission using basic epidemiological tools ..."
@DrTedros @WHO @HelenBranswell @mvankerkhove “We're all kind of fed up with this and we want this to be over. But this should push us even further, to have even more resolve to end this pandemic”, says @mvankerkhove. "We cannot lose this battle now."
@DrTedros @WHO @HelenBranswell @mvankerkhove "We need to try and contain any virus, whatever the variant is, in situ”, says @DrMikeRyan. “Shutting down countries with absolute measures is neither feasible in the world we live in nor is it necessarily the most effective public health action to take."
@DrTedros @WHO @HelenBranswell @mvankerkhove @DrMikeRyan "It's really important that transparent and open countries like South Africa and the UK, who pursue science on behalf of all of us are not unduly or unnecessarily punished for their openness and their pursuit of science”, says @DrMikeRyan.
@DrTedros @WHO @HelenBranswell @mvankerkhove @DrMikeRyan Q about vaccinated people traveling to countries with little virus.
"I don't believe we have the evidence on any of the vaccines to be confident that it's going to prevent people from actually getting the infection and therefore being able to pass it on”, says @doctorsoumya.
@DrTedros @WHO @HelenBranswell @mvankerkhove @DrMikeRyan @doctorsoumya Important to reflect on what vaccines are for, says @DrMikeRyan: “The first primary objective is to decrease the impact that this disease is having on people's lives. And therefore, that will be a major step forward and bringing the world back to some kind of normal."
@DrTedros @WHO @HelenBranswell @mvankerkhove @DrMikeRyan @doctorsoumya Second phase is looking at how vaccine affects transmission, says @DrMikeRyan. “The decision then to move towards elimination or eradication of the virus requires a much higher degree of efficiency and effectiveness in a vaccination program and all of the other control measures."
@DrTedros @WHO @HelenBranswell @mvankerkhove @DrMikeRyan @doctorsoumya "First and foremost, we have to focus on saving lives, getting good control of this epidemic so our societies can return to normal”, says @DrMikeRyan. “And then we will deal with the moonshot of potentially being able to eliminate or eradicate this virus."
@DrTedros @WHO @HelenBranswell @mvankerkhove @DrMikeRyan @doctorsoumya “This is not necessarily the big one”, says @DrMikeRyan. "This virus is very transmissible, and it kills people and it has deprived so many people of loved ones, but its current case fatality is reasonably low in comparison to other emerging diseases."
@DrTedros @WHO @HelenBranswell @mvankerkhove @DrMikeRyan @doctorsoumya "The planet is fragile”, says @DrMikeRyan. “These threats will continue. If there's one thing we need to take from this pandemic with all of the tragedy and loss, it's that we need to get our act together. We need to get ready for something that may even be more severe in future"
@DrTedros @WHO @HelenBranswell @mvankerkhove @DrMikeRyan @doctorsoumya “For me personally, it's not just COVID alone”, says @drtedros. "Ethiopia is in trouble. And the devastating war that's happening is actually in my home country, in my home region, Tigray.” Says he has not been able to communicate with family there incl. his younger brother.
@DrTedros @WHO @HelenBranswell @mvankerkhove @DrMikeRyan @doctorsoumya “Whatever the situation is, I believe it can change”, says @DrTedros. "I call on the global community to choose peace, to choose solidarity, to choose caring for one another, caring for each other."

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Kai Kupferschmidt

Kai Kupferschmidt Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @kakape

29 Dec
"Although there is no information that infections with these strains are more severe, due to increased transmissibility the impact of #COVID19 disease in terms of hospitalisations and deaths is assessed as high."

@ECDC_EU risk assessment of new variants:
ecdc.europa.eu/en/publication…
@ECDC_EU "The probability of increased circulation of any SARS-CoV-2 strains and this placing greater pressure on health systems in the coming weeks is considered to be high due to the festive season and, higher still, in countries where the new variants are established."
@ECDC_EU "The UK has demonstrated that their sequencing programme is able to detect emerging variants. Ideally, Member States should aim for a similar timeliness and fraction of samples sequenced, although this will depend on the availability of resources."
Read 5 tweets
29 Dec
Finally read the new update on UK variant B.1.1.7, posted yesterday, which includes a study suggesting the variant is no more (or less) severe than prior virus variants.
Just a very brief thread (or read the entire document here:
assets.publishing.service.gov.uk/government/upl…)
Researchers took 1769 cases of people infected with the new variant and then looked for 1769 cases of people with “normal” virus to compare them to. They chose these so that median age and proporion of females was the same. That’s why it’s called a “matched cohort study”
They then compared hospitalizations for the two groups:
Overall 42 people were hopsitalized,
16 with the variant
26 with wild-type
The difference between the two was not significant.
Read 10 tweets
26 Dec
For all those still arguing that “only" around 0,1% of people infected with #covid19 die:
This is nonsense!
The US has around 330 million people and it has now recorded more than 330,000 deaths.
That means 0,1% of the *entire population* has died. And #sarscov2 still spreading.
UK:
about 66 million people
more than 69,000 deaths from #covid19

France: about 67 million people
more than 62,000 deaths

Mexico:
about 126 million population
more than 121,000 deaths

Even worse:
Belgium:
11,5 million population
more than 19,000 deaths
We had a lot of good data already showing that the IFR of #covid19 is much higher than 0,1%.

Now we have a lot of places where around 0,1% of the entire population have died and the virus is still spreading.

So anyone still telling this lie, is deliberately ignoring reality.
Read 5 tweets
24 Dec
What do we know about the new #SARSCoV2 variants? How worried should we be? What does it mean?
I promised to summarize the main points from my reporting over the last few days.
So here is my latest story and a thread (and then it’s Christmas)
sciencemag.org/news/2020/12/u…
First: I’ve said “We don’t know yet” a lot over the last few days and we still don’t know most of what we want to know about these variants. Getting good answers takes times. Science takes time. But we are learning a lot fast and we know a lot more today than three days ago.
The UK variant:
I explained how B.1.1.7 caught scientists’ attention in my first story on this and why they were worried (sciencemag.org/news/2020/12/m…).
That worry has only increased. There is now more data available and it points to this variant really being more transmissible.
Read 20 tweets
22 Dec
Some good news (and incredibly fast work) on one of the mutations scientists are worried about: N501Y.
In these lab experiments serum from recovered #covid19 patients was just as good at neutralizing virus with the mutation as without it.
This does not say anything about whether the mutation could make the virus more transmissible but it suggest the mutation alone at least does not mean the virus can widely infect people again.
Of course, both UK and SA variant have several additional mutations...
I will let other people figure out how to cite a tweet in a scientific publication ;)
Read 5 tweets
21 Dec
It’s becoming clearer that one main hypothesis that scientists are looking at with B.1.1.7 is whether its advantage could be that it is better at infecting children. There are a TON of caveats, but this is one possibility that is being explored.
The idea is very simple: #SARSCoV2 appears to be a bit worse at infecting children than adults. If the mutations in B.1.1.7 allow this variant to bind more tightly to the ACE2 receptor on human cells that could essentially make it as good at infecting children as adults.
Like I said a TON of caveats. Maybe most importantly: the UK had a lockdown while schools were kept open, so you would expect the epidemic to shift more to children anyway and that of course can make it look like there is something going on with this variant in children.
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!